Collaboration Key To Chinese Innovation And Global Ambitions – China Healthcare Investment Conference
This article was originally published in The Pink Sheet Daily
Executive Summary
BGI CEO Jun Wang and Simcere Founder Jisheng Ren share views on collaboration and talent retention in China.
You may also be interested in...
Merck And BGI Sign Global Deal Focused On Biomarkers, Genomics
After announcing the intent to form a partnership a year ago, Merck & Co. announced Sept. 13, a collaboration with BGI (formerly the Beijing Genomics Institute) for discovery and development of biomarkers and genomic technologies
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues.
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.